chr10-101009290-ATCT-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4_SupportingPP5
The NM_001195263.2(PDZD7):c.2675_2677del(p.Lys892del) variant causes a inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000391 in 1,535,908 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000043 ( 0 hom. )
Consequence
PDZD7
NM_001195263.2 inframe_deletion
NM_001195263.2 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.47
Genes affected
PDZD7 (HGNC:26257): (PDZ domain containing 7) This gene encodes a ciliary protein homologous to proteins which are mutated in Usher syndrome patients, and mutations and translocations involving this gene have been associated with two types of Usher syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_001195263.2. Strenght limited to Supporting due to length of the change: 1aa.
PP5
Variant 10-101009290-ATCT-A is Pathogenic according to our data. Variant chr10-101009290-ATCT-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 44131.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Pathogenic=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDZD7 | NM_001195263.2 | c.2675_2677del | p.Lys892del | inframe_deletion | 16/17 | ENST00000619208.6 | NP_001182192.1 | |
PDZD7 | XM_011540177.4 | c.2675_2677del | p.Lys892del | inframe_deletion | 17/18 | XP_011538479.1 | ||
PDZD7 | XM_011540178.4 | c.2672_2674del | p.Lys891del | inframe_deletion | 16/17 | XP_011538480.1 | ||
PDZD7 | XM_047425767.1 | c.2675_2677del | p.Lys892del | inframe_deletion | 16/17 | XP_047281723.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDZD7 | ENST00000619208.6 | c.2675_2677del | p.Lys892del | inframe_deletion | 16/17 | 5 | NM_001195263.2 | ENSP00000480489 | P1 | |
PDZD7 | ENST00000474125.7 | c.*2622_*2624del | 3_prime_UTR_variant, NMD_transcript_variant | 12/13 | 2 | ENSP00000474447 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152174Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
1
AN:
152174
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000365 AC: 5AN: 136880Hom.: 0 AF XY: 0.0000538 AC XY: 4AN XY: 74410
GnomAD3 exomes
AF:
AC:
5
AN:
136880
Hom.:
AF XY:
AC XY:
4
AN XY:
74410
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000426 AC: 59AN: 1383734Hom.: 0 AF XY: 0.0000469 AC XY: 32AN XY: 682816
GnomAD4 exome
AF:
AC:
59
AN:
1383734
Hom.:
AF XY:
AC XY:
32
AN XY:
682816
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152174Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74340
GnomAD4 genome
AF:
AC:
1
AN:
152174
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
74340
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 27, 2023 | This variant, c.2675_2677del, results in the deletion of 1 amino acid(s) of the PDZD7 protein (p.Lys892del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs397516636, gnomAD 0.02%). This variant has been observed in individual(s) with congenital sensorineural hearing loss (PMID: 34387732). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 44131). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. For these reasons, this variant has been classified as Pathogenic. - |
Hearing loss, autosomal recessive 57 Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | Service de Biologie Medicale, CIUSSS du Saguenay-Lac-Saint-Jean | Dec 01, 2019 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 14, 2013 | Variant classified as Uncertain Significance - Favor Benign. The Lys892del in PD ZD7 has not been reported in the literature nor previously identified by our lab oratory. This variant results in an in-frame single amino acid deletion in exon 16 which is only present in an alternate longer transcript of PDZD7, with the ma jor transcript only encoding 10 exons. Furthermore, there is inconclusive eviden ce as to the role of the PDZD7 gene in hearing loss or Usher syndrome. No bialle lic mutations have been found in Usher patients to date despite screening in 205 cases (Ebermann 2010, Besnard 2012). Instead, there is one case report suggesti ng PDZD7 may be a modifier of the severity of Usher syndrome (Ebermann 2010). In addition, there is a second case report suggesting PDZD7 could cause nonsyndrom ic hearing loss based upon a patient with a homozygous translocation that disrup ts the long alternate isoform of PDZD7 (Schneider 2009). It should be noted that the affected individual did not have evidence of retinal disease at age 8 but a dditional evaluations beyond age 8 have not been reported. In summary, additiona l data is needed to determine the clinical significance of this variant; however , based upon the uncertain role of PDZD7 in hearing loss and Usher syndrome and the presence of an alternate cause of hearing loss in this patient, we would lea n towards a more likely benign role. - |
PDZD7-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 07, 2024 | The PDZD7 c.2675_2677delAGA variant is predicted to result in an in-frame deletion (p.Lys892del). This variant was reported in the homozygous or compound heterozygous states along with a premature termination variant in three individuals with hearing loss from two families (Cruz Marino et al. 2022. PubMed ID: 34387732). This variant is reported in 0.016% of alleles in individuals of African descent in gnomAD. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at